Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
2.430
+0.165 (7.28%)
Nov 4, 2024, 4:00 PM EST - Market closed
Syros Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -97.82 | -164.57 | -94.65 | -86.56 | -84.04 | -75.44 | Upgrade
|
| Depreciation & Amortization | 1.34 | 2.25 | 2.71 | 3.02 | 3.04 | 2.72 | Upgrade
|
| Other Amortization | 0.57 | 0.57 | 5.71 | 0.71 | 0.29 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | - | - | - | - | -0.18 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.14 | 0.52 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.3 | -1.31 | 0.24 | 0.22 | -0.05 | -0.95 | Upgrade
|
| Stock-Based Compensation | 7.25 | 10.43 | 11.41 | 10.35 | 10.94 | 9.84 | Upgrade
|
| Other Operating Activities | -14.46 | 37.35 | -42.96 | -16.68 | 0.38 | - | Upgrade
|
| Change in Accounts Receivable | 1.67 | 1.69 | 1.29 | -0.65 | 17.83 | -20.16 | Upgrade
|
| Change in Accounts Payable | 6.79 | 5.13 | 2.77 | 0.05 | -1.06 | 1.49 | Upgrade
|
| Change in Unearned Revenue | -0.14 | -4.33 | -5.85 | -11.91 | -6.29 | 18.18 | Upgrade
|
| Change in Other Net Operating Assets | -4.93 | 2.56 | -3.72 | 1.9 | 1.61 | 4.24 | Upgrade
|
| Operating Cash Flow | -100.02 | -109.71 | -123.07 | -99.54 | -57.36 | -60.25 | Upgrade
|
| Capital Expenditures | -0.04 | -0.27 | -1.24 | -1.25 | -3.34 | -12.64 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.69 | 1.56 | - | - | - | 0.11 | Upgrade
|
| Investment in Securities | 0.3 | 36.05 | 68.43 | -51.41 | 50 | 0.79 | Upgrade
|
| Investing Cash Flow | 1.95 | 37.34 | 67.19 | -52.65 | 46.66 | -11.73 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 39.62 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.07 | -0.59 | -0.27 | -0.24 | -0.21 | Upgrade
|
| Net Debt Issued (Repaid) | -0 | -0.07 | -0.59 | -0.27 | 39.38 | -0.21 | Upgrade
|
| Issuance of Common Stock | 43.5 | 43.53 | 119.98 | 70.82 | 103.78 | 61.56 | Upgrade
|
| Other Financing Activities | -0.34 | - | 11.66 | -0.04 | -0.21 | - | Upgrade
|
| Financing Cash Flow | 43.16 | 43.46 | 131.05 | 70.51 | 142.95 | 65.99 | Upgrade
|
| Net Cash Flow | -54.91 | -28.91 | 75.17 | -81.68 | 132.25 | -6 | Upgrade
|
| Free Cash Flow | -100.05 | -109.98 | -124.31 | -100.79 | -60.7 | -72.89 | Upgrade
|
| Free Cash Flow Margin | -25920.73% | -1106.87% | -835.39% | -429.09% | -402.17% | -3677.65% | Upgrade
|
| Free Cash Flow Per Share | -2.72 | -3.88 | -9.84 | -16.12 | -13.18 | -18.12 | Upgrade
|
| Cash Interest Paid | 5.28 | 4.55 | 3.41 | 3.19 | 1.51 | 0.07 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 0.01 | 0.03 | Upgrade
|
| Levered Free Cash Flow | -57.94 | -66.66 | -66.58 | -50.79 | -18.45 | -67.03 | Upgrade
|
| Unlevered Free Cash Flow | -55.18 | -64.03 | -64.69 | -49.05 | -17.62 | -66.99 | Upgrade
|
| Change in Net Working Capital | -5.97 | -2.62 | 3.66 | -0.96 | -23.18 | 18.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.